VJHemOnc is committed to improving our service to you

MPN Advances Day 2019 | Allo-transplant for myelofibrosis

VJHemOnc is committed to improving our service to you

Donal McLornan

Donal McLornan, MB BCh, MRCP, PhD, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses the retrospective study by the European Society for Blood and Marrow Transplantation (EBMT) Chronic Malignancies Working Party on myeloablative and reduced-intensity conditioning allo-transplant for myelofibrosis. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter